Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: LCLLCL Resources LimitedMaterials

LCL Signs Second PNG Farm-In With Rio Tinto at Liamu

LCL Resources signed a binding term sheet under which Rio Tinto may earn up to 80% of the Liamu copper-gold project in PNG, subject to ministerial approval.

By Digifin Pty Ltd · About this coverage

Key Points

  • Rio Tinto may earn an initial 51% by sole funding at least A$6 million
  • Path to 80% via a further A$40 million or a 1Mt copper resource and Scoping Study
  • LCL to be Operator with a management fee of up to 10%
  • Subject to PNG ministerial approval and registration of the term sheet
LCL Resources Limited (ASX:LCL)

About LCL Resources (ASX:LCL)

LCL Resources Limited is an ASX-listed mineral exploration company headquartered in Perth. It explores for copper and gold, with a portfolio of exploration licences in Papua New Guinea.

LCL Resources (ASX:LCL) has signed a second Papua New Guinea farm-in with Rio Tinto, bringing outside funding to its undrilled Liamu copper-gold project.

Under a binding farm-in and joint venture term sheet, Rio Tinto Exploration (PNG) Limited may earn an initial 51% of the Liamu Project by sole funding at least A$6 million of exploration, including at least 3,000m of drilling, within five years. It may move to 80% by sole funding a further A$40 million, or by defining a JORC-compliant Mineral Resource of at least 1Mt copper (or copper equivalent) and completing a Scoping Study. Rio Tinto must sole fund a minimum of A$200,000 within 12 months of obtaining land access before it may withdraw. LCL will be Operator and receive a management fee of up to 10% of exploration expenditure, although Rio Tinto may elect to become Operator. Initial work will target undrilled catchments around the Dada porphyry discovery, where trenching returned 96m @ 0.41g/t Au, and Rio Tinto will review further work at the Ubei prospect within 12 months. The project is Exploration Licence EL2432, about 120km to 150km east-southeast of Port Moresby.

The farm-in provisions are subject to PNG ministerial approval, registration of the term sheet and the licence extension applications not being rejected. If these are not satisfied or waived by 30 September 2027, either party may terminate. Neither prospect has been drill tested.

Back to all ASX Company News

Source: LCL Resources Limited (ASX:LCL), 26 October 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Monday, 26 October 2026

Also summarised today

All ASX Company News
ASX: BSLMaterials

BlueScope Lifts 1H FY27 EBIT Guidance to Near $1.1B

BlueScope now expects 1H FY2027 underlying EBIT approaching $1.1 billion, above its $860–$960 million range, on stronger US steel spreads at North Star.

26 Oct, 8:29 am AEDT
ASX: CGFFinancials

Challenger Board Rejects TDA's $11.80 Indicative Offer

Challenger's Board said TAL Daiichi Life Australia's $11.80 per share indicative offer is not at a level it could recommend, but it intends to keep engaging.

26 Oct, 9:51 am AEDT
ASX: COHHealth Care

Cochlear Holds FY27 Profit Guidance of $330M to $350M

Cochlear reaffirmed FY27 underlying net profit guidance of $330 million to $350 million at its 2026 AGM, after FY26 underlying net profit of $322 million.

26 Oct, 8:33 am AEDT
ASX: INAReal Estate

Ingenia Receives $5.35 Indicative Proposal From AVID

Ingenia received a non-binding AVID proposal of $5.35 cash per stapled security, up to $5.40 with a distribution, and granted up to six weeks' soft exclusivity.

26 Oct, 9:57 am AEDT
ASX: LOTEnergy

Lotus Secures Final Permit for First Kayelekera Export

Lotus Resources secured Namibian export approval, completing key permits for its first Kayelekera shipment of approximately 145k lbs of U3O8, due in November.

26 Oct, 9:32 am AEDT
ASX: MYXHealth Care

Mayne Pharma 1Q FY27 Underlying EBITDA Falls to $5.3M

Mayne Pharma reported unaudited 1Q FY27 revenue of $95.7 million and underlying EBITDA of $5.3 million, down 52%, as Dermatology sales fell on generic entry.

26 Oct, 8:49 am AEDT
ASX: OFXFinancials

OFX Exclusivity With Equals Ends, 2Q27 NOI $45.3m

OFX said exclusivity with Equals ended after its $1.00 per share proposal was not reconfirmed, and reported 2Q27 Net Operating Income of $45.3m, up 3.1%.

26 Oct, 9:19 am AEDT
ASX: RMSMaterials

Ramelius Produces 48,839oz, Holds FY27 Gold Guidance

Ramelius produced 48,839 ounces at an AISC of A$2,656/oz after wet weather slowed Penny haulage, lifted cash and gold to A$768 million and kept FY27 guidance.

26 Oct, 8:26 am AEDT
ASX: SYRMaterials

Syrah Secures US$15M DFC Disbursement for Balama

Syrah Resources will receive a further US$15 million DFC loan disbursement for Balama after DFC temporarily waived existing events of default on the loan.

26 Oct, 9:20 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital